Journal article
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy
Abstract
PURPOSE: Radio-recurrent prostate cancer is typically detected by a rising prostate-specific antigen and may reflect local or distant disease. Positron emission tomography (PET) radiotracers targeting prostate-specific membrane antigen, such as 18F-DCFPyL have shown promise in restaging men with recurrent disease postprostatectomy but are less well characterized in the setting of radio-recurrent disease.
METHODS AND MATERIALS: A prospective, …
Authors
Liu W; Zukotynski K; Emmett L; Chung HT; Chung P; Wolfson R; Rachinsky I; Kapoor A; Metser U; Loblaw A
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 106, No. 3, pp. 546–555
Publisher
Elsevier
Publication Date
March 2020
DOI
10.1016/j.ijrobp.2019.11.001
ISSN
0360-3016